We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.23B
AUM Growth
+$298M
(+4.3%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
2.07%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
1,100
New
151
Increased
415
Reduced
333
Closed
164
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$40.6M |
| 2 |
Autodesk
ADSK
|
+$38.8M |
| 3 |
Intuit
INTU
|
+$37.1M |
| 4 |
Ecolab
ECL
|
+$35.6M |
| 5 |
Coca-Cola
KO
|
+$35.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$51.9M |
| 2 |
EOG Resources
EOG
|
+$33.8M |
| 3 |
DATA
Tableau Software, Inc.
DATA
|
+$32M |
| 4 |
Microsoft
MSFT
|
+$29.8M |
| 5 |
Ford
F
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Financials | 17.68% |
| 3 | Consumer Discretionary | 13.74% |
| 4 | Industrials | 11.53% |
| 5 | Healthcare | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
DXC Technology
DXC
$1.63B
| $6.7M | 0.09% |
+121,560
| New | +$7.03M |
|
277
Portland General Electric
POR
$6.02B
| $6.68M | 0.09% |
123,360
+46,000
| +59% | +$2.43M |
|
278
NovoCure
NVCR
$2.04B
| $6.68M | 0.09% |
105,623
+190
| +0.2% | +$9.63K |
|
|
NUAN
279
DELISTED
Nuance Communications, Inc.
NUAN
| $6.66M | 0.09% |
481,516
-327,136
| -40% | -$4.82M |
|
280
Bank OZK
OZK
$5.49B
| $6.65M | 0.09% |
+221,150
| New | +$6.85M |
|
281
Insight Enterprises
NSIT
$3.55B
| $6.64M | 0.09% |
114,084
+104,594
| +1,102% | +$5.83M |
|
282
Graham Holdings Company
GHC
$4.97B
| $6.58M | 0.09% |
9,535
+1,686
| +21% | +$1.18M |
|
283
Kelly Services Class A
KELYA
$526M
| $6.51M | 0.09% |
248,680
+16,550
| +7% | +$396K |
|
284
Manhattan Associates
MANH
$8.97B
| $6.51M | 0.09% |
93,927
-57,313
| -38% | -$3.69M |
|
285
Primoris Services
PRIM
$4.69B
| $6.5M | 0.09% |
310,297
+3,300
| +1% | +$67.6K |
|
286
Sunstone Hotel Investors
SHO
$2.19B
| $6.46M | 0.09% |
471,231
+351,881
| +295% | +$4.98M |
|
287
Equity Residential
EQR
$25.4B
| $6.39M | 0.09% |
84,145
-10
| -0% | -$764 |
|
|
DMC
288
Del Monte Corp
DMC
$1.35B
| $6.38M | 0.09% |
236,537
+960
| +0.4% | +$26.2K |
|
289
Lockheed Martin
LMT
$134B
| $6.38M | 0.09% |
17,535
-18,669
| -52% | -$6.25M |
|
|
FIT
290
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $6.32M | 0.09% |
1,435,384
+232,270
| +19% | +$1.17M |
|
291
Olin
OLN
$2.64B
| $6.28M | 0.09% |
286,830
-29,280
| -9% | -$652K |
|
|
MOBL
292
DELISTED
MobileIron, Inc.
MOBL
| $6.28M | 0.09% |
1,013,220
+253,407
| +33% | +$1.43M |
|
293
UMB Financial
UMBF
$10.7B
| $6.28M | 0.09% |
95,407
+16,190
| +20% | +$1.07M |
|
294
First Hawaiian
FHB
$3.42B
| $6.27M | 0.09% |
242,265
-58,380
| -19% | -$1.54M |
|
295
Evercore
EVR
$13.1B
| $6.25M | 0.09% |
70,601
-90,389
| -56% | -$8.04M |
|
296
Target
TGT
$62.1B
| $6.25M | 0.09% |
72,160
+13,310
| +23% | +$1.08M |
|
297
XPO
XPO
$25B
| $6.21M | 0.09% |
310,738
+121,352
| +64% | +$2.47M |
|
|
TGNA
298
DELISTED
TEGNA Inc
TGNA
| $6.21M | 0.09% |
409,897
-367,660
| -47% | -$5.66M |
|
|
GLUU
299
DELISTED
Glu Mobile Inc.
GLUU
| $6.16M | 0.09% |
858,047
-25,500
| -3% | -$234K |
|
|
AEL
300
DELISTED
American Equity Investment Life Holding Company
AEL
| $6.14M | 0.08% |
225,967
-13,460
| -6% | -$385K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2019 Portfolio in Review
As of Q2 2019, Jacobs Levy Equity Management held 1,100 positions worth $7.23B, up 4.3% from $6.93B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jacobs Levy Equity Management's Q2 2019 filing shows 151 new, 415 increased, 333 reduced and 164 closed positions. Its largest new stake was Biogen: 175,817 shares worth $41.1M. The largest sale was Allergan plc, an estimated $51.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2019 buy was Biogen: 175,817 shares worth $41.1M.
- Jacobs Levy Equity Management added most to Ecolab in Q2 2019, an estimated $35.6M increase.
- Jacobs Levy Equity Management's biggest Q2 2019 reduction was EOG Resources, cutting an estimated $33.8M.
- Jacobs Levy Equity Management fully exited Allergan plc in Q2 2019, selling an estimated $51.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 15% of its $7.23B portfolio in Q2 2019.
- Jacobs Levy Equity Management opened 151 new positions and closed 164 in Q2 2019.
- Jacobs Levy Equity Management's portfolio value rose 4.3% quarter-over-quarter to $7.23B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2019, filed 13 Aug 2019.